Aug 2026· RSC Chemical Biology· Vol 7, pp. 1958-1971· 0 citations· 2 references
Medicine
TL;DR
It is proposed that the order of kinases in cascades is dictated by their conformational character, a mechanism amplified in cascade-enriched biomolecular condensates—establishing design principles for pathway-selective, cascade-directed therapeutics.
Abstract
A fundamental question in cell signaling is how a single kinase, with a single primary substrate, can activate multiple distinct cellular programs. Kinases can be characterized by speed, duration, and amplitude. They should be efficient—but not necessarily maximally—as signaling functions often require slow kinetics. How the physical behavior of individual kinases, especially the top-tier kinase, coordinates the collective cascade for functional output—essential for molecular engineering and pharmacology—remains a challenge. Here we decipher the structural “why” behind the specific kinase order in cascades as the key design principle of cellular signaling, which resolves these questions. We elucidate the conformational mechanisms and catalytic actions of the sequentially ordered component kinases in seven related and distinct cascades, including MAPKs. We propose that the order of kinases in cascades is dictated by their conformational character, a mechanism amplified in cascade-enriched biomolecular condensates—establishing design principles for pathway-selective, cascade-directed therapeutics.
The mitogen-activated protein kinase (MAPK) signaling pathway is a central oncogenic signaling axis, with BRAF functioning as a critical regulatory node. The discovery of oncogenic BRAF mutations, most notably BRAFV600E, enabled the development of targeted therapies that significantly improved clinical outcomes in seve...
Jayhind Bharti, Priyadharshini Gogu, Dhanashree N. Sarwan et al.· Biochemical Pharmacology· 0 citations
This work introduces a two-stage generative diffusion modeling framework designed to support pathway discovery in protein complexes, demonstrated using RAF kinase dimerization, a key event for kinase activation and oncogenic signaling.
Tim Hsu, Konstantia Georgouli, Michael C. Jones et al.· Machine Learning: Science an...· 0 citations
It is shown that inhibitor size and flexibility affect binding mechanisms and have implications on kinetics, distinct from previous computational studies.
A. Shinobu, Suyong Re, Hiraku Oshima et al.· Journal of Physical Chemistr...· 0 citations
These findings establish BE scanning as a scalable approach for network-level chemical-genetic interaction mapping, revealing new mechanistic insights into one of the most studied oncogenic pathways.
James Woods, C. X. Hu, Dong-Man Jang et al.· bioRxiv· 0 citations
Together, these examples define an expanding pharmacological vocabulary for kinase drug discovery: one that asks not only whether a molecule inhibits its target kinase, but how ligand binding rewires protein stability, interactions, localisation, and function.
J. Diepeveen, Z. Kozicka· Chimia (Basel)· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.